To identify candidate genes which mediate the depressive side effects of IFN-α, microarray analysis of the primary transcriptional response to IFN-α was performed in those 11 patients that developed depression during therapy in comparison to 11 randomly chosen HCV patients that did not experience such side effects. Here, IFNA1 is linked to major depressive disorder.